We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Synairgen Plc | LSE:SNG | London | Ordinary Share | GB00B0381Z20 | ORD 1P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.08 | 1.31% | 6.20 | 5.52 | 7.00 | 6.20 | 6.20 | 6.20 | 84,000 | 14:20:29 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Pharmaceutical Preparations | 0 | -17.65M | -0.0876 | -0.71 | 12.48M |
| Date | Subject | Author | Discuss |
|---|---|---|---|
| 14/11/2020 08:31 | Update 6 hours ago. www.synairgen.com 6 hours ago — The SG016 trial randomised 101 hospitalised COVID-19 patients to either SNG001, Synairgen's inhaled formulation of interferon beta-1a, or placebo. Positive ... Covid-19 · News · IFN-β (SNG001) in COPD · About us | duck_and_dive | |
| 14/11/2020 08:14 | "Synairgen soars after positive news from drug trial"...to 30% below where it was on Monday morning... | sloppyjoe2 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
